Cargando…
Sentinel Lymph Node Detection in Colorectal Cancer – First Experience
BACKGROUND: Colorectal cancer (CRC) is the second commonest cancer in women, the third in men, being the fourth commonest cause of cancer death. The most important factor for prognosis and staging in CRC patients is the status of the regional lymph nodes (LN). AIM: To implement the method for sentin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672113/ https://www.ncbi.nlm.nih.gov/pubmed/29123574 http://dx.doi.org/10.3889/oamjms.2017.166 |
_version_ | 1783276361988702208 |
---|---|
author | Stojanoski, Sinisa Manevska, Nevena Antovic, Svetozar Pop-Gjorcheva, Daniela Vaskova, Olivija Miladinova, Daniela Mileva, Magdalena |
author_facet | Stojanoski, Sinisa Manevska, Nevena Antovic, Svetozar Pop-Gjorcheva, Daniela Vaskova, Olivija Miladinova, Daniela Mileva, Magdalena |
author_sort | Stojanoski, Sinisa |
collection | PubMed |
description | BACKGROUND: Colorectal cancer (CRC) is the second commonest cancer in women, the third in men, being the fourth commonest cause of cancer death. The most important factor for prognosis and staging in CRC patients is the status of the regional lymph nodes (LN). AIM: To implement the method for sentinel lymph node (SLN) detection in CRC patients using radiocolloid, and test its detection rate, sensitivity, accuracy, negative predictive value and the possibility for upstaging. MATERIAL AND METHODS: The study included 40 CRC patients, age 63 ± 14 years, without LNs detected on CT or MRI. SLN detection was performed after endoscopically peri- and intratumoral injection of 99mTc-SENTISCINT. All patients underwent resection with systemic lymphadenectomy, and the SLNs were detected ex vivo. Pathohistology was performed to all resected LNs. RESULTS: The identification rate was 95%, the accuracy of the procedure was 92.1%, the negative predictive value was 86.95%, the sensitivity was 83.3%, and the upstage was 22.5%. CONCLUSION: Identification of SLNs in CRC patients with this method is possible and the detection rate, negative predictive value, accuracy and sensitivity are reliable. We expect to contribute in the upstaging of stage II CRC patients and the selection of appropriate oncology treatment protocols. |
format | Online Article Text |
id | pubmed-5672113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Republic of Macedonia |
record_format | MEDLINE/PubMed |
spelling | pubmed-56721132017-11-09 Sentinel Lymph Node Detection in Colorectal Cancer – First Experience Stojanoski, Sinisa Manevska, Nevena Antovic, Svetozar Pop-Gjorcheva, Daniela Vaskova, Olivija Miladinova, Daniela Mileva, Magdalena Open Access Maced J Med Sci Clinical Science BACKGROUND: Colorectal cancer (CRC) is the second commonest cancer in women, the third in men, being the fourth commonest cause of cancer death. The most important factor for prognosis and staging in CRC patients is the status of the regional lymph nodes (LN). AIM: To implement the method for sentinel lymph node (SLN) detection in CRC patients using radiocolloid, and test its detection rate, sensitivity, accuracy, negative predictive value and the possibility for upstaging. MATERIAL AND METHODS: The study included 40 CRC patients, age 63 ± 14 years, without LNs detected on CT or MRI. SLN detection was performed after endoscopically peri- and intratumoral injection of 99mTc-SENTISCINT. All patients underwent resection with systemic lymphadenectomy, and the SLNs were detected ex vivo. Pathohistology was performed to all resected LNs. RESULTS: The identification rate was 95%, the accuracy of the procedure was 92.1%, the negative predictive value was 86.95%, the sensitivity was 83.3%, and the upstage was 22.5%. CONCLUSION: Identification of SLNs in CRC patients with this method is possible and the detection rate, negative predictive value, accuracy and sensitivity are reliable. We expect to contribute in the upstaging of stage II CRC patients and the selection of appropriate oncology treatment protocols. Republic of Macedonia 2017-09-15 /pmc/articles/PMC5672113/ /pubmed/29123574 http://dx.doi.org/10.3889/oamjms.2017.166 Text en Copyright: © 2017 Sinisa Stojanoski, Nevena Manevska, Svetozar Antovic, Daniela Pop-Gjorcheva, Olivija Vaskova, Daniela Miladinova, Magdalena Mileva. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). |
spellingShingle | Clinical Science Stojanoski, Sinisa Manevska, Nevena Antovic, Svetozar Pop-Gjorcheva, Daniela Vaskova, Olivija Miladinova, Daniela Mileva, Magdalena Sentinel Lymph Node Detection in Colorectal Cancer – First Experience |
title | Sentinel Lymph Node Detection in Colorectal Cancer – First Experience |
title_full | Sentinel Lymph Node Detection in Colorectal Cancer – First Experience |
title_fullStr | Sentinel Lymph Node Detection in Colorectal Cancer – First Experience |
title_full_unstemmed | Sentinel Lymph Node Detection in Colorectal Cancer – First Experience |
title_short | Sentinel Lymph Node Detection in Colorectal Cancer – First Experience |
title_sort | sentinel lymph node detection in colorectal cancer – first experience |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672113/ https://www.ncbi.nlm.nih.gov/pubmed/29123574 http://dx.doi.org/10.3889/oamjms.2017.166 |
work_keys_str_mv | AT stojanoskisinisa sentinellymphnodedetectionincolorectalcancerfirstexperience AT manevskanevena sentinellymphnodedetectionincolorectalcancerfirstexperience AT antovicsvetozar sentinellymphnodedetectionincolorectalcancerfirstexperience AT popgjorchevadaniela sentinellymphnodedetectionincolorectalcancerfirstexperience AT vaskovaolivija sentinellymphnodedetectionincolorectalcancerfirstexperience AT miladinovadaniela sentinellymphnodedetectionincolorectalcancerfirstexperience AT milevamagdalena sentinellymphnodedetectionincolorectalcancerfirstexperience |